Resources & Multimedia

ODs Share Real-World Experience Using CooperVision’s MiSight 1 day Contact Lenses

Sponsored Content

March 1, 2021

Review of Myopia Management Editor-in-Chief John Sailer recently interviewed three optometrists certified in CooperVision’s Brilliant Futures program to hear about their experiences with the company’s MiSight 1 day contact lenses.

These lenses have garnered a lot of attention, as MiSight 1 day contact lenses are currently the only FDA-approved soft contact lenses with proven results in slowing myopia progression in patients starting as young as 8.* During this conversation, the optometrists Dr. Justin Kwan, Dr. Andrew Neukirch, and Dr. Brianna Rhue all came to the same consensus: CooperVision’s MiSight 1 day contact lenses produced great results from a medical standpoint and also went over well with young patients and their parents.

*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-67.

2 Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622-60.

3 Bullimore M. Myopia Control: Why each dioptre matters. BCLA 2019 Poster.

4 Tideman JW et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134:1355-1363.

5 CooperVision data on file 2019. Chamberlain P, Logan N, Jones D, Gonzalez-Meijome J, Saw S-M, Young G. Clinical evaluation of a dual-focus myopia control 1 day soft contact lens: 3-year results (2016 American Academy of Optometry Annual Meeting) and 5-year results (2019 BCLA Clinical Conference & Exhibition).

6 Bullimore MA. The Safety of Soft Contact Lenses in Children. Optom Vis Sci 2017;94:638-46.

7 Mayer DL, Hansen RM, Moore BD, Kim S, Fulton AB. Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol. 2001;119(11):1625-1628. doi:10.1001/archopht.119.11.1625

8 Zadnik K, Sinnott LT, Cotter SA, et al. Prediction of Juvenile-Onset Myopia. JAMA Ophthalmol. 2015;133(6):683-689. doi:10.1001/jamaophthalmol.2015.0471

To Top